America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
"Biden administration plans to curtail U.S. investments in Chinese tech sectors to prevent aiding China's military advancements, focusing on semiconductors, ...